Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial
Wirksamkeit einer ARMOR-Tool-basierten Deprescribing-Intervention zur Reduktion des Sturzrisikos bei älteren Patient:innen mit fallrisikoerhöhenden Arzneien (DeFRID-Studie): Protokoll einer randomisierten kontrollierten Studie
JMIR Research Protocols · 2024-06-11 · 13 · e55638
DOI: 10.2196/55638 ↗Auf einen Blick
Das Protokoll beschreibt eine randomisierte Studie zu ARMOR-basiertem Deprescribing bei 60- bis 80-Jährigen mit mindestens 1 FRID. Untersucht werden Sturzrate und Veränderungen der Sturzrisikoscores.
Fragestellung
Ist eine auf dem ARMOR-Tool basierende Deprescribing-Intervention wirksam, um Stürze bei älteren Patient:innen mit FRIDs zu reduzieren, und wie kosteneffektiv ist sie?
Methode
Offene, parallele, randomisierte kontrollierte akademische Studie; Ärzt:innen werden stratifiziert nach Seniorität randomisiert; Follow-up über 1 Jahr mit monatlichen Telefonkontakten und 3-monatlichen Untersuchungen.
Ergebnisse
Geplante Endpunkte sind Sturzhäufigkeit, Veränderungen der Sturzrisikoscores, Kosten-Effektivität mit inkrementellem Kosten-Effektivitäts-Verhältnis sowie unerwünschte Ereignisse nach Deprescribing.
Schlussfolgerung der Autor:innen
Die Studie soll Hinweise zur Wirksamkeit des ARMOR-Tools zur Reduktion von Stürzen bei älteren Menschen mit FRIDs sowie zur Kosteneffektivität des Deprescribing liefern.
Kernaussagen
- Protokoll einer offenen, parallelen RCT
- Population: 60- bis 80-Jährige mit ≥5 Arzneien und ≥1 FRID
- Endpunkte: Stürze, Sturzrisiko-Scores, Kosteneffektivität, unerwünschte Ereignisse
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2024-06-11. Written by Rekha Priyadarshini and 9 co-authors. Institution: Department of Pharmacology, All India Institute of Medical Sciences Bibinagar, Hyderabad, India. Major MEDLINE topics: Accidental Falls, Deprescriptions. Cited 4 times so far (Crossref); 15 references. The full text is freely available in PubMed Central.
Topics: Sturzprophylaxe
Abstract (original language)
Background
Falls in older patients can lead to serious health complications and increased health care costs. Fall risk–increasing drugs (FRIDs) are a group of drugs that may induce falls or increase the tendency to fall (ie, fall risk). Deprescribing is the process of withdrawal from an inappropriate medication, supervised by a health care professional, with the goal of managing polypharmacy and improving outcomes.
Objective
This study aims to assess the effectiveness of a deprescribing intervention based on the Assess, Review, Minimize, Optimize, and Reassess (ARMOR) tool in reducing the risk of falls in older patients and evaluate the cost-effectiveness of deprescribing FRIDs.
Methods
This is an open-label, parallel-group randomized controlled academic trial. Individuals aged 60-80 years who are currently taking 5 or more prescribed drugs, including at least 1 FRID, will be recruited. Demographic data, medical conditions, medication lists, orthostatic hypotension, and fall history details will be collected. Fall concern will be assessed using the Fall Efficacy Scale, and fall risk will be assessed by the Timed Up and Go test and Tinetti Performance-Oriented Mobility Assessment tool. In this study, all treating physicians will be randomized using a stratified randomization method based on seniority. Randomized physicians will do deprescribing with the ARMOR tool for patients on FRIDs. Participants will maintain diaries, and monthly phone follow-ups will be undertaken to monitor falls and adverse events. Physical assessments will be performed to evaluate fall risk every 3 months for a year. The rationality of prescription drugs will be evaluated using the World Health Organization’s core indicators.
Results
The study received a grant from the Indian Council of Medical Research–Safe and Rational Use of Medicine in October 2023. The study is scheduled to commence in April 2024 and conclude by 2026. Efficacy will be measured by fall frequency and changes in fall risk scores. Cost-effectiveness analysis will also include the incremental cost-effectiveness ratio calculation. Adverse events related to deprescription will be recorded.
Conclusions
This trial will provide essential insights into the efficacy of the ARMOR tool in reducing falls among the geriatric population who are taking FRIDs. Additionally, it will provide valuable information on the cost-effectiveness of deprescribing practices, offering significant implications for improving the well-being of older patients and optimizing health care resource allocation. The findings from this study will be pertinent for health care professionals, policy makers, and researchers focused on geriatric care and fall prevention strategies. Trial Registration Clinical Trials Registry – India CTRI/2023/12/060516; https://ctri.nic.in/Clinicaltrials/pubview2.php International Registered Report Identifier (IRRID) PRR1-10.2196/55638
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pharmacology, All India Institute of Medical Sciences Bibinagar, Hyderabad, India.
- Department of General Medicine, All India Institute of Medical Sciences Bibinagar, Hyderabad, India.
- Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bibinagar, Hyderabad, India.
- Division of Development Research, Indian Council of Medical Research Head Quarters, New Delhi, India.
- Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry, India.
- Department of Geriatric Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
ORCID profiles: Rekha Priyadarshini, Madhavi Eerike, Sakthivadivel Varatharajan, Gomathi Ramaswamy, Gerard Marshall Raj, Jerin Jose Cherian, Priyadharsini Rajendran, Venugopalan Gunasekaran, Shailaja V Rao, Venu Gopala Rao Konda
Cite
APA
Priyadarshini, R., Eerike, M., Varatharajan, S., Ramaswamy, G., Raj, G. M., Cherian, J. J., Rajendran, P., Gunasekaran, V., Rao, S. V., & Konda, V. G. R. (2024). Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 13, e55638. https://doi.org/10.2196/55638
Vancouver
Priyadarshini R, Eerike M, Varatharajan S, Ramaswamy G, Raj GM, Cherian JJ, et al. Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2024;13:e55638. doi:10.2196/55638
BibTeX
@article{Priyadarshini2024,
author = {Priyadarshini, Rekha and Eerike, Madhavi and Varatharajan, Sakthivadivel and Ramaswamy, Gomathi and Raj, Gerard Marshall and Cherian, Jerin Jose and Rajendran, Priyadharsini and Gunasekaran, Venugopalan and Rao, Shailaja V and Konda, Venu Gopala Rao},
title = {Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2024},
volume = {13},
pages = {e55638},
doi = {10.2196/55638}
}
EUVIMED